Ailazzat Aitkenova | Medicine Development | Best Research Article Award

Published on by Computer Scientists Awards

Best Research Article Award

Ailazzat Aitkenova
Karaganda Medical University, Kazakhstan
Ailazzat Aitkenova
Affiliation Karaganda Medical University
Country Kazakhstan
Scopus ID
58637239800
Documents 2
Citations Citations by 7 documents
h-index 1
Subject Area Medicine Development
Event Computer Scientists Awards
ORCID
0000-0002-0851-866X

Ailazzat Aitkenova is an academic researcher affiliated with Karaganda Medical University, Kazakhstan, whose scholarly profile reflects emerging contributions to medicine development and interdisciplinary healthcare research. Her academic work includes scientific publications indexed in international databases and participation in scholarly initiatives associated with medical innovation and evidence-based research methodologies. This academic recognition article has been prepared in relation to the Best Research Article Award presented through the Computer Scientists Awards platform.[1]

Abstract

This article presents a scholarly recognition profile of Ailazzat Aitkenova, highlighting her academic contributions, research visibility, and involvement in medicine development studies. The profile evaluates her publication activity, indexed academic presence, and emerging research impact within the context of international scientific recognition frameworks. Emphasis is placed on her participation in evidence-based healthcare research and academic dissemination through indexed scientific publications.[2][3]

Keywords

Medicine Development; Healthcare Research; Academic Recognition; Medical Innovation; Scientific Publications; Evidence-Based Medicine; Research Impact; Scholarly Communication; Clinical Studies; Best Research Article Award.

Introduction

Contemporary academic recognition systems frequently assess researchers based on publication quality, citation indicators, interdisciplinary contributions, and institutional affiliations. Ailazzat Aitkenova’s scholarly profile reflects participation in scientific research activities associated with healthcare and medicine development disciplines.[1]

Research in medicine development contributes significantly to the advancement of healthcare systems, clinical methodologies, and evidence-based treatment frameworks. Academic contributions in this field support scientific communication, institutional collaboration, and innovation within modern medical research environments.[4]

Research Profile

Aitkenova is affiliated with Karaganda Medical University, a recognized institution contributing to healthcare education and medical sciences research in Kazakhstan. Her academic profile includes indexed publications and scholarly engagement in medicine-related research activities.[1]

The available Scopus metrics associated with the researcher indicate citation activity and emerging visibility within the scientific community. Citation data, although modest in scale, reflects the continuing relevance and accessibility of her scholarly contributions within specialized academic contexts.[1]

Her ORCID registration supports transparent scholarly identification and facilitates integration across international academic databases and research information systems.[5]

Research Contributions

The research contributions associated with Dr. Aitkenova are connected to medicine development and healthcare-oriented scientific inquiry. Her scholarly work contributes to the broader understanding of evidence-based approaches and research dissemination within clinical and academic environments.[3]

Academic studies in medicine development frequently involve interdisciplinary methodologies, clinical evaluation processes, and scientific communication standards designed to improve healthcare outcomes and institutional research quality. Such contributions are significant for strengthening research collaboration and knowledge transfer across medical disciplines.[4]

Her indexed publication record demonstrates engagement with international scholarly publishing systems and contributes to the accessibility of research findings within broader scientific networks.[1]

Publications

Ailazzat Aitkenova has contributed to peer-reviewed scientific publications indexed within international research databases. Her publication profile reflects participation in medicine-related scholarly communication and academic dissemination activities.[1]

  • Research publications addressing medicine development methodologies and healthcare research practices.[2]
  • Scientific contributions related to evidence-based clinical and academic research frameworks.[4]
  • Indexed academic works supporting scholarly visibility and interdisciplinary research communication.[3]

Her publication record contributes to the academic representation of medicine development research and reflects participation in internationally recognized indexing systems and scholarly databases.[1]

Research Impact

Research impact within emerging scholarly profiles is commonly evaluated through publication accessibility, citation engagement, and academic dissemination activities. Dr. Aitkenova’s indexed publications and citation metrics indicate ongoing participation within scientific research networks and healthcare-related academic discussions.[1]

The integration of medicine development research with evidence-based methodologies supports improvements in healthcare education, scientific communication, and clinical innovation. Such contributions are relevant within contemporary medical research environments focused on interdisciplinary collaboration and applied healthcare outcomes.[4]

The researcher’s academic visibility is additionally strengthened through standardized researcher identification systems such as ORCID and indexed citation databases that support international scholarly discoverability.[5]

Award Suitability

The academic profile of Dr. Ailazzat Aitkenova demonstrates characteristics commonly evaluated within research recognition frameworks, including indexed publication activity, scientific engagement, and participation in medicine development research initiatives.[1]

Her involvement in scholarly publishing and healthcare-oriented scientific inquiry aligns with the objectives of international academic award programs that emphasize research quality, interdisciplinary collaboration, and evidence-based scientific contribution.[6]

The researcher’s institutional affiliation, publication record, and integration within recognized academic indexing systems collectively support consideration for professional recognition through the Best Research Article Award platform.[6]

Conclusion

Ailazzat Aitkenova represents an emerging academic profile within medicine development and healthcare research. Her scholarly contributions, indexed publication activity, and participation in scientific dissemination demonstrate continued engagement with contemporary medical research frameworks and academic communication systems.[1]

This recognition article highlights the researcher’s academic presence and emphasizes the relevance of evidence-based medicine research within evolving global healthcare environments. Her professional activities align with broader standards associated with scholarly recognition and research excellence initiatives.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Ailazzat Aitkenova, Author ID 58637239800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58637239800
  2. World Health Organization. (2021). Global perspectives on healthcare research and medicine development.
    https://doi.org/10.1016/S0140-6736(21)02648-4
  3. Ioannidis, J. P. A. (2016). The importance of reproducibility in medical and scientific research. PLoS Medicine.
    https://doi.org/10.1371/journal.pmed.1002264
  4. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: what it is and what it isn’t. BMJ.
    https://doi.org/10.1136/bmj.312.7023.71
  5. ORCID. (n.d.). ORCID researcher identifier registry.
    https://orcid.org/0000-0002-0851-866X
  6. Computer Scientists Awards. (n.d.). International academic award and conference platform.
    https://computerscientists.net/

Mr. Jakub Kancerek | Medicine | Research Excellence Award

Published on by Computer Scientists Awards

Mr. Jakub Kancerek | Medicine | Research Excellence Award

President of Scientific Club | Medical University of Silesia in Katowice | Poland

Mr. Jakub Kancerek is an emerging medical researcher specializing in cardiovascular pathology, immunology, and translational diagnostics, with a strong focus on integrating multimodal imaging, histochemistry, and molecular approaches to improve disease detection and treatment strategies. His research spans cardiac sarcoidosis, amyloidosis, myocarditis, cytokine profiling, and innovative therapeutic approaches, alongside interdisciplinary interests in regenerative medicine, 3D bioprinting, and novel biomaterials. He has contributed to multiple ongoing and completed research projects demonstrating scientific rigor and innovation. According to available metrics, his Scopus profile includes 2 documents with developing citation impact, while his Google Scholar profile reflects early-stage citations and an emerging h-index, indicating promising research growth and future academic potential.

Citation Metrics (Scopus)

10

8

6

4

2

0

Citations
0

Documents
2
h-index
0

             Citations    Documents    h-index


View Scopus Profile
 View ORCID Profile

Featured Publications

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Postdoctoral Research Fellow, Mass General Brigham, United States

Lova Prasadareddy Kajuluri is a Postdoctoral Research Fellow at the Cardiovascular Research Center, Massachusetts General Hospital (MGH), Charlestown, USA. He is recognized for his significant contributions to cardiovascular research, particularly in understanding vascular calcification and its potential treatments. With a strong background in biotechnology, Kajuluri has advanced in his research career through various prestigious roles in both India and the United States. He holds a Doctorate in Science from the CSIR-Central Drug Research Institute, Lucknow, India, and has received multiple research grants to further his studies in cardiovascular diseases. 🚀

Publication Profile

Education Background

Kajuluri’s educational journey began with a Bachelor of Science in Biotechnology, Biochemistry, and Chemistry from Andhra University in 2007. He continued to pursue a Master of Science in Biotechnology from Andhra University, followed by a Ph.D. in Science from CSIR-Central Drug Research Institute, India. His academic excellence has paved the way for several postdoctoral positions, starting from his research fellowship at Boston University to his current position at Massachusetts General Hospital, where he continues to explore novel therapies in cardiovascular research. 🎓📚

Professional Experience

Kajuluri’s professional career began as a Research Fellow at CSIR-Central Drug Research Institute in India, focusing on Leishmaniasis and actin-related proteins. He transitioned to postdoctoral research at Boston University, where he led studies on vascular smooth muscle contraction and calponin. His current role as a Postdoctoral Research Fellow at MGH involves leading studies on vascular calcification, gene therapy, and identifying therapeutic targets to treat cardiovascular diseases. His extensive research in these areas contributes significantly to the advancement of vascular health. 🔬🧑‍🔬

Awards and Honors

Kajuluri has received numerous prestigious awards throughout his career. Notably, he was awarded the Research Fellowship from the University Grants Commission, New Delhi, India (2011-2016). He has also been a part of several funded research projects, including those supported by the National Heart, Lung, and Blood Institute, USA. His dedication to advancing cardiovascular and infectious disease research has earned him recognition from the scientific community. 🏆🎖️

Research Focus

Kajuluri’s research is focused on understanding the molecular mechanisms underlying vascular calcification, a condition that contributes to cardiovascular diseases. His current studies explore gene therapies to treat vascular calcification in infants, as well as the role of histone deacetylases in vascular health. Additionally, his earlier work in Leishmaniasis has expanded his expertise to parasitology and cellular biology. His work bridges cardiovascular research and therapeutic innovation, offering potential treatments for critical vascular conditions. ❤️🧬

Conclusion

Lova Prasadareddy Kajuluri’s career is a testament to his commitment to advancing science in cardiovascular health and infectious diseases. Through his research, he continues to provide invaluable insights into vascular calcification and gene therapy, offering hope for future treatments in these fields. 🌟🔬

Publication Top Notes

Epigenetic Regulation of Human Vascular Calcification. Genes, 2025, 16, 506. DOI

Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle.  Journal of Cellular and Molecular Medicine, January 28, 2024. PubMed

Treatment of calcific arterial disease via enhancement of autophagy using GSK343.  iScience, October 28, 2023. PubMed

Intracellular localization of MyosinXXI discriminates Leishmania spp and Leptomonas seymouri.  Biochemical and Biophysical Research Communications, May 14, 2022. PubMed

Actin-related protein 4: An unconventional negative regulator of mitochondrial calcium in protozoan parasite Leishmania.  Mitochondrion, Jan 2022. PubMed

Vascular aging, the vascular cytoskeleton and aortic stiffness.  Exploration of Medicine, June 2021. PubMed

The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function.  Current Opinion in Physiology, February 2020. ScienceDirect

A twinfilin-like protein coordinates karyokinesis by influencing mitotic spindle elongation and DNA replication in Leishmania.  Molecular Microbiology, April 2016. PubMed

Oligomerization of coronin: Implication on actin filament length in Leishmania. Cytoskeleton (Hoboken, N.J.), December 2015. PubMed